Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Faucher, Sylvie ^a   Crawley, Angela M ^b,c   Decker, Wendy ^a   Sherring, Alice ^a   Bogdanovic, Dragica ^a   Ding, Tao ^a   Bergeron, Michele ^a   Angel, Jonathan B ^b,c,d   Sandstrom, Paul ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR, ALPHA CHAIN; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN;

ANTIGEN SPECIFICITY; ARTICLE; BIOTINYLATION; CALIBRATOR; CONTROLLED STUDY; FREEZE THAWING; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNODETECTION; IMMUNOREACTIVITY; NORMAL HUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; ADULT; BLOOD; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; REFERENCE VALUE; SOLUBILITY;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-7; REFERENCE VALUES; SOLUBILITY;

EID: 68949207154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006690     Document Type: Article

References (49)

1. Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174: 6571-6576.
2. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, et al. (1994) A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 22: 321-328.
3. Ray RJ, Furlonger C, Williams DE, Paige CJ (1996) Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol 26: 10-16.
4. Tonozuka Y, Fujio K, Sugiyama T, Nosaka T, Hirai M, et al. (2001) Molecular cloning of a human novel type I cytokine receptor related to delta1/TSLPR. Cytogenet Cell Genet 93: 23-25.
5. Ziegler SF, Liu YJ (2006) Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7: 709-714.
6. Giliani S, Mori L, de Saint BG, Le DF, Rodriguez-Perez C, et al. (2005) Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 203: 110-26.:110-26.
7. Roifman CM, Zhang J, Chitayat D, Sharfe N (2000) A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 96: 2803-2807.
8. McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, et al. (2008) Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun 9: 1-6.
9. McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, et al. (2008) CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis. J Autoimmun 31: 52-58.
10. Read SW, Higgins J, Metcalf JA, Stevens RA, Rupert A, et al. (2006) Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy. J Acquir Immune Defic Syndr 42: 537-544.
11. Benito JM, Lopez M, Lozano S, Gonzalez-Lahoz J, Soriano V (2008) Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy. J Infect Dis 198: 1466-1473.
12. Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F, et al. (2005) Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 19: 2077-2086.
13. Paiardini M, Cervasi B, Albrecht H, Muthukumar A, Dunham R, et al. (2005) Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol 174: 2900-2909.
14. Vingerhoets J, Bisalinkumi E, Penne G, Colebunders R, Bosmans E, et al. (1998) Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett 61: 53-61.
15. MacPherson PA, Fex C, Sanchez-Dardon J, Hawley-Foss N, Angel JB (2001) Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr 28: 454-457.
16. Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, et al. (2006) IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur J Immunol 36: 336-344.
17. Sasson SC, Zaunders JJ, Kelleher AD (2006) The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. Curr Drug Targets 7: 1571-1582.
18. Colle JH, Moreau JL, Fontanet A, Lambotte O, Delfraissy JF, et al. (2007) The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients. AIDS 21: 101-103.
19. Vranjkovic A, Crawley AM, Gee K, Kumar A, Angel JB (2007) IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int Immunol 19: 1329-1339.
20. Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, et al. (1990) Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60: 941-951.
21. Pleiman CM, Gimpel SD, Park LS, Harada H, Taniguchi T, et al. (1991) Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter. Mol Cell Biol 11: 3052-3059.
22. Korte A, Kochling J, Badiali L, Eckert C, Andreae J, et al. (2000) Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all. Cytokine 12: 1597-1608.
23. Teutsch SM, Booth DR, Bennetts BH, Heard RN, Stewart GJ (2003) Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur J Hum Genet 11: 509-515.
24. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, et al. (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39: 1083-1091.
25. Carini C, McLane MF, Mayer KH, Essex M (1994) Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. Eur J Immunol 24: 2927-2934.
26. Blom-Potar MC, Bugault F, Lambotte O, Delfraissy JF, Theze J (2009) Soluble IL-7Ralpha (sCD127) and measurement of IL-7 in the plasma of HIV patients. J Acquir Immune Defic Syndr 51: 104-105.
27. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
28. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM (2007) Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 319: 41-52.
29. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
30. Wang Y, Dai H, Liu Z, Cheng X, Tellides G, et al. (2006) Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade. Am J Transplant 6: 2851-2860.
31. Antons AK, Wang R, Kalams SA, Unutmaz D (2008) Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals. PLoS One 3: e2952.
32. Fernandez-Botran R, Gorantla V, Sun X, Ren X, Perez-Abadia G, et al. (2002) Targeting of glycosaminoglycan-cytokine interactions as a novel therapeutic approach in allotransplantation. Transplantation 74: 623-629.
33. Witkowska AM (2005) On the role of sIL-2R measurements in rheumatoid arthritis and cancers. Mediators Inflamm. pp 121-130.
34. Gotoh Y, Okamoto Y, Uemura O, Mori N, Tanaka S, et al. (1999) Determination of age-related changes in human soluble interleukin 2 receptor in body fluids of normal subjects as a control value against disease states. Clin Chim Acta 289: 89-97.
35. Richards JM, Mick R, Latta JM, Daly K, Ratain MJ, et al. (1990) Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood 76: 1941-1945.
36. Viviani S, Camerini E, Bonfante V, Santoro A, Balzarotti M, et al. (1998) Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. Br J Cancer 77: 992-997.
37. Maier LM, Anderson DE, Severson CA, Baecher-Allan C, Healy B, et al. (2009) Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol 182: 1541-1547.
38. Selinsky CL, Howell MD (2000) Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo. Cell Immunol 200: 81-87.
39. Rose-John S, Scheller J, Elson G, Jones SA (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80: 227-236.
40. Stoklasek TA, Schluns KS, Lefrancois L (2006) Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol 177: 6072-6080.
41. Mortier E, Bernard J, Plet A, Jacques Y (2004) Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol 173: 1681-1688.
42. Mortier E, Quemener A, Vusio P, Lorenzen I, Boublik Y, et al. (2006) Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 × IL-15R alpha fusion proteins. J Biol Chem 281: 1612-1619.
43. Lang KS, Recher M, Navarini AA, Harris NL, Lohning M, et al. (2005) Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur J Immunol 35: 738-745.
44. Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, et al. (2006) Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44: 1098-1109.
45. Boutboul F, Puthier D, Appay V, Pelle O, Ait-Mohand H, et al. (2005) Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 19: 1981-1986.
46. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, et al. (2001) Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7: 73-79.
47. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, et al. (2008) Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 205: 1701-1714.
48. Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, et al. (2009) Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 119: 997-1007.
49. Faucher S, Martel A, Sherring A, Ding T, Malloch L, et al. (2004) Protein bead array for the detection of HIV-1 antibodies from fresh plasma and dried-bloodspot specimens. Clin Chem 50: 1250-1253.